Fundacion de la Hemofilia
About Fundacion de la Hemofilia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Fundacion de la Hemofilia
During the past decade, Fundacion de la Hemofilia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Dose Ranging Study of RPL554 in Chronic Obstructive Pulmonary Disease (COPD) Patients
2017-06-01
2018-02-07
Completed
405
Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
2018-12-01
2023-03-24
Completed
407
A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
2021-10-05
2025-03-01
Recruiting
1,290
Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV
2021-12-21
2025-01-15
Recruiting
150
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion de la Hemofilia"
#1 collaborator was "Sintesi Research Srl" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Fundacion de la Hemofilia
According to Clinical.Site data, the most researched conditions in "Fundacion de la Hemofilia" are
"Hemophilia A" (2 trials). Many other conditions were trialed in "Fundacion de la Hemofilia" in a lesser frequency.
Clinical Trials Intervention Types at Fundacion de la Hemofilia
Most popular intervention types in "Fundacion de la Hemofilia" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Moroctocog alfa (AF-CC)" (1 trials), "PLASMA DERIVED Factor VIII" (1 trials) and "Recombinant FVIII" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fundacion de la Hemofilia
The vast majority of trials in "Fundacion de la Hemofilia" are
2 trials for "Male" genders.
Clinical Trials Status at Fundacion de la Hemofilia
Currently, there are NaN active trials in "Fundacion de la Hemofilia".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Fundacion de la Hemofilia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fundacion de la Hemofilia, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".